EN
HI
Concord Drugs Share price
CONCORD
56.31
2.68 (5.00%)Last updated on 26 Aug, 2025 | 15:03 IST
BUYSELL
Today's High
56.31
Today's Low
56.00
52 Week Low
26.10
52 Week High
67.00
The current prices are delayed, login to your account for live prices
LoginConcord Drugs Chart
Concord Drugs Share Key Metrics
Volume
4264.00
Market Cap
53.63 CR
LTQ@LTP
6@56.31
ATP
56.3
Var Margin
100 %
Circuit Range
50.95-56.31
Delivery %
0 %
Value
2.40 L
ASM/GSM
No
Market Lot
1
Concord Drugs Corporate Actions
| Date | Agenda | |
|---|---|---|
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | |
| 2025-05-23 | Audited Results | |
| 2025-03-17 | Preferential Issue of shares & Others | |
| 2025-03-13 | Preferential Issue of shares & Others | |
| Date | Record Date | ||
|---|---|---|---|
 | |||
Concord Drugs News
BRIEF-Concord Drugs Says Approved Sale Of Non-Agricultural/Industrial Land, Ground, With Structures In Uttarakhand State
Oct 13 2020 19:21:03
Read More
About Concord Drugs
NSE : 0
BSE : 538965
ISIN : INE858L01010
CONCORD DRUGS LIMITED a company with its registered office at 5-9-22/36 Adarsha Nagar Hyderabad - 500463 (With effect from 14196 as for resolution dated 1.4.96 Change of Registered Office is being file with ROC was incorporated as a public limited company on 24th April 1995. The factory of the company is situated at survey No.s 248-251 Torruru Village Brahmanapally post Hyathnagar mandal R.R.Dist. Andhra Pradesh. The main objects of the company is to carry on the business of manufacturing and selling of pharmaceuticals formulations i.e. Tablets Capsules Liquids and Sterile Powder Injections Bio Adhesive and Radio Opec agent.SUBSIDIARIES OF THE COMPANYThe company has no subsidiary.
Concord Drugs Management
| Name | Position |
|---|---|
| Mr. S Nagi Reddy | Chairman & Managing Director |
| Mr. S Manoj Kumar Reddy | Whole Time Director |
| Mr. S Koni Reddy | WholeTime Director & CFO |
| Mr. K Ramachandra Reddy | Independent Director |
| Ms. Sumeela Kasu | Independent Director |
Concord Drugs Similar Stocks
Aspira Pathlab & Diagnostics Ltd.
62.00
0.50 (0.81%)
NG Industries Ltd.
144.55
-3.50 (2.36%)
Shree Pacetronix Ltd.
157.70
3.09 (2.00%)
Vineet Laboratories Ltd.
34.78
-0.01 (0.03%)
Centenial Surgical Suture Ltd.
125.25
-13.30 (9.60%)
Amkay Products Ltd.
55.50
-0.50 (0.89%)
Chandra Bhagat Pharma Ltd.
55.65
0.00 (0.00%)
Medicamen Organics Ltd.
0.00
0.00 (0.00%)
Sandu Pharmaceuticals Ltd.
49.20
0.13 (0.26%)
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 56.31 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 131.87. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 1.64. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 32.96 & 3.68 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 53.63 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 67.00 & 26.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.